Genetic knockout of AMPK or FOXO1 abrogated the protective effects of rFGF4 against diabetes-induced renal injury, underscoring the critical role of the AMPK-FOXO1 axis in mediating the therapeutic effects of FGF4 in DKD. Here, PRKAA2 is linked to diabetic kidney disease.